Former Director‑Officer Sharpe Buys 1.5 M Shares of ConexEU, Selling Warrant Hedge Amid Regulatory Uncertainty
Insider buying at Conexeu Sciences shows executive confidence despite a 65% YTD drop—discover what Sharpe’s 500k‑share purchase signals for investors.
3 minutes to read